A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...

Q3 2025 Earnings Call November 5, 2025 1:00 AM ESTCompany ParticipantsKazumi Tamaki - Executive Officer and GM of ...

LRT Capital reports +9.52% October gains, critiques AI hype, and backs undervalued picks like ABG. Discover why fundamentals ...